MediWound Ltd. (MDWD)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $13.55
- As of
Kresmion compiles this page from MDWD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
MediWound Ltd. (MDWD): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-11-12.
See the full MDWD dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MDWD on one page. Preview it with sample data, then open it live with a free account.
Preview the MDWD dossierActive events for MDWD
- mediumEarnings above estimates
Q3-2026: Beat consensus by 9.8%, EPS $-0.65 vs $-0.7208 estimate
- high13F: large increase
Point72 Asset Management, L.P. added +188% to MDWD (2026Q1)
- mediumEarnings above estimates
Q1-2026: Beat consensus by 65.6% - EPS $-0.23 vs $-0.6681 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 110.9% - EPS $-1.23 vs $-0.5831 estimate
- mediumEarnings above estimates
Q3-2025: Beat consensus by 71.0% - EPS $-0.24 vs $-0.8279 estimate
FREE, NO ACCOUNT
Every event on MDWD, as it fires
You are seeing 5 of 7 events recorded on MDWD since 2026-06-05.
The five above landed across 4 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, MDWD
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
More data on MDWD
MDWD against its peers
MDWD's operating margin of -149.0% ranks in the 59th percentile of 15 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.
| Metric | MDWD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 17.0M USD | 16.6M USD | 50 | 16 |
| Revenue YoY | -16.1% | -15.9% | 42 | 5 |
| Gross margin | 19.2% | 82.8% | 19 | 7 |
| Operating margin | -149.0% | -221.7% | 59 | 15 |
| Net margin | -140.8% | -233.7% | 62 | 16 |
| Return on equity | -54.7% | -40.0% | 46 | 22 |
| 1 year | -24.1% | -6.7% | 42 | 24 |
Peers (24): KRRO, PYXS, WHWK, SLGL, KROS, ANIK, ELDN, RNAC, ARTV, CGEN, PRQR, TRDA, ANTX, ACOG, IFRX, BBOT, IVVD, PALI, NGEN, ZNTL, NAGE, STRO, ACIU, IKT. Left out: HSTC (period gap). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (MDWD: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in MDWD on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on MDWD in the last 180 days.
Upstream: SEC EDGAR filings for MDWD
Kresmion, "MediWound Ltd. (MDWD) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/MDWD. Upstream data: SEC EDGAR filings for MDWD.
Link to this data (HTML):
<a href="https://kresmion.com/research/MDWD">MediWound Ltd. (MDWD) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow MDWD on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to MDWD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.